Zydus Lifesciences Strengthens Urology Portfolio with USFDA Approval of Methenamine Hippurate Tablets

Unknown Apr 02, 2026 800 Views

Zydus Lifesciences Limited announced the final USFDA approval for Methenamine Hippurate Tablets. This brings an important enhancement to Zydus's strengthening portfolio of urological therapeutics. Most significant points: The approved therapeutic is indicated...